Bioretec Oy

Bioretec Oy

BRETEC · HE · Healthcare / Medical Devices

0.0246EUR+0.00 (+8.85%)

Price History

Full chart

Market Stats

Previous Close0.0226
Open0.0246
Day Range0.023 – 0.0252
52-Week Range0.0108 – 1.58
Volume4.05M
Market Cap35.69M
P/E (TTM)0.14
Forward P/E0.00
EPS0.19
Dividend Yield0.00%
50-Day Avg0.0242
200-Day Avg0.1499

About

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Sarah Van Hellenberg Hubar-Fisher
  • Employees0
  • HeadquartersYrittäjänkulma 5, Tampere, Finland, 33710, Finland
  • Websitehttps://bioretec.com

Leadership

  • Ms. Sarah Van Hellenberg Hubar-FisherChief Executive Officer · b. 1978
  • Anna-Mari VenolaInterim CFO & Controller
  • Mr. Rene EveDirector of Operations
  • Mr. Conan CavanaghHead of Research & Development

Financials

Income Statement

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.75M1.50M2.00M2.94M3.91M4.54M3.52M
Growth (%)--14.15%+33.59%+46.88%+32.78%+16.32%-22.49%
Cost of Revenue500.90K398.20K627.70K806.73K1.18M1.32M1.21M
Gross Profit1.25M1.10M1.38M2.14M2.73M3.22M2.31M
Gross Margin71.32%73.44%68.66%72.58%69.84%70.89%65.72%
Operating Expense2.98M3.03M4.04M4.43M5.76M7.42M11.00M
Operating Income-1.74M-1.92M-2.67M-2.29M-3.03M-4.20M-8.69M
Operating Margin-99.48%-128.39%-133.10%-77.90%-77.67%-92.48%-246.64%
EBITDA-1.58M-1.77M-2.50M-2.11M-2.73M-3.87M-8.36M
EBITDA Margin-90.21%-118.29%-124.66%-71.79%-69.90%-85.12%-237.48%
Net Income-1.73M-2.26M-6.02M-2.42M-3.79M-4.61M-9.48M
Net Income Margin-99.34%-150.66%-300.39%-82.13%-96.99%-101.54%-269.27%
Interest Expense27.70K346.60K3.35M123.62K856.51K590.05K1.31M
Interest Expense % of Total Revenue1.59%23.12%167.27%4.20%21.93%12.99%37.17%

Balance Sheet

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.63M3.89M8.58M3.49M10.66M11.47M11.68M
Total Liabilities2.90M2.53M4.24M1.57M2.43M1.74M1.92M
Total Equity-1.26M1.36M4.34M1.92M8.23M9.74M9.76M
Cash58.00K2.27M162.49K207.34K3.78M3.84M4.13M
Net Debt2.05M-1.81M505.59K---

Cash Flow

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.22M-2.00M-2.39M-2.36M-3.44M-5.11M-9.76M
Investing Cash Flow--121.20K-393.28K-260.40K-161.35K-728.77K-583.74K
Financing Cash Flow-4.33M7.13M-2.78M9.29M5.21M8.18M
Capital Expenditure00393.28K260.40K161.35K728.77K583.74K
Free Cash Flow-1.22M-2.00M-2.78M-2.62M-3.60M-5.84M-10.35M
FCF to OCF100.00%100.00%116.48%111.03%104.69%114.27%105.98%

Earnings

Report DateMay 16, 2024Aug 15, 2024Nov 19, 2024Feb 14, 2025Mar 31, 2025Aug 14, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Aug 13, 2026
EPS Estimate-0.05-0.05-0.07-0.06-0.06-0.04-0.10-0.060.00-
EPS Actual-0.05-0.04-0.07-0.12--0.12----0.00
Surprise0.00%20.00%0.00%-100.00%--200.00%----
TimingPre-marketPre-marketPre-marketPre-market-Pre-market---Pre-market

Key Statistics & Ratios

Market Cap35.69M
Enterprise Value34.95M
Trailing P/E0.14
Forward P/E0.00
Price / Sales10.26
Price / Book2.15
EPS0.19
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-4861.06%
Return on Assets0.00%
Shares Outstanding1.34B
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%